Publications by authors named "Alaa Shahbar"

Claim this Profile
C
Cardiovascular safety of CDK4/6 inhibitors in advance breast cancer: Assessing risks of QTc prolongation and thrombosis.
Alaa Shahbar

J Oncol Pharm Pract· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Posaconazole versus voriconazole as antifungal prophylaxis for invasive fungal diseases in patients with hematological malignancies.
Reem Almutairy, Mansoor Ahmed Khan, Alaa Shahbar, Mohammed Aseeri, Majed Alshamrani

J Oncol Pharm Pract· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Trial Awareness, Perceptions, and Participation Among Cancer Patients in Saudi Arabia.
Maryam Alotaibi, Laila Alsolami, Sarah AlHarbi, Amal Alagha, Lina Alqurashi, Alaa Shahbar

Healthcare (Basel)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venous Thromboembolism in Cancer: Predictors of Recurrence and Bleeding in Patients on Direct Oral Anticoagulants.
Alaa Shahbar, Afnan Noor, Alqassem Y Hakami, Abdulfattah Y Alhazmi, Bassim Albeirouti

J Clin Med· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of Direct Oral Anticoagulants Apixaban and Rivaroxaban Versus Standard Therapy for VTE Prophylaxis Post Cancer Surgery-A Network Meta-Analysis of Randomized Clinical Trials.
Alaa Shahbar, Abdulaziz Alawlqi, Abdullah Alhifany, Afnan Noor, Abdulaali R Almutairi

J Clin Med· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of Cardiotoxicity Incidence in Patients Receiving HER-2-Targeted Therapies for Breast Cancer in Saudi Arabia.
Alaa Shahbar, Abdullah A Alhifany, Yasser M Alatawi, Mohammed Alnuhait, Abdullah Alshammari

Clin Med Insights Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and discontinuation rate of immune checkpoint inhibitors used in patients with solid and hematological malignancies. A population based retrospective analysis.
Alaa Shahbar, Majed Alshamrani, Mohammed Aseeri, Turki Alfayea, Abdelmajid Alnatsheh

J Oncol Pharm Pract· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of olanzapine, neurokinin-1 receptor antagonists, and thalidomide in combination with palonosetron plus dexamethasone in preventing highly emetogenic chemotherapy-induced nausea and vomiting: a Bayesian network meta-analysis.
Abdullah A Alhifany, Ali McBride, Abdulaali R Almutairi, Ejaz Cheema, Alaa Shahbar

Support Care Cancer· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing the efficacy and safety of faecal microbiota transplantation with bezlotoxumab in reducing the risk of recurrent infections: a systematic review and Bayesian network meta-analysis of randomised controlled trials.
Abdullah A Alhifany, Abdulaali R Almutairi, Thamer A Almangour, Alaa N Shahbar, Ivo Abraham

BMJ Open· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis